The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Company Data

Name ProShares UltraShort Nasdaq Biotechnology

Company ProShares UltraShort Nasdaq Biotechnology

Symbol BIS

Primary Exchange

NASDAQ

ISIN US74347G8380

Asset Class ETF

Sector Financial Services

Industry Asset Management

Country United States of America

Currency USD

Employees -

IPO Date 2010-04-09

Dividends from 'ProShares UltraShort Nasdaq Biotechnology'

Ex-Date	Dividend per Share
26.03.2025	0,13 USD
23.12.2024	0,21 USD
25.09.2024	0,15 USD
26.06.2024	0,16 USD
20.03.2024	0,16 USD
20.12.2023	0,18 USD
20.09.2023	0,12 USD
21.06.2023	0,02 USD
25.03.2020	0,03 USD
24.12.2019	0,04 USD

Ticker Symbols

Name	Symbol
NASDAQ	BIS

More Shares

Investors who hold ProShares UltraShort Nasdaq Biotechnology also have the following shares in their portfolio:

ENGIE 23/27 MTN Bond

FLYHT AEROSPACE SOLUTIONS Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog